结核病治疗的最新情况:对当前实践的范围审查
Sofia R Lopes1,2, Mariana Marçal3,2, Nicole Fernandes4,2
1Local Unit of Health Cova da Beira, Covilhã, Portugal.
Breathe (Sheffield, England)
|March 19, 2025
概括
较新的结核病 (TB) 治疗方法,包括较短的疗程,对耐药性结核病 (DS-TB) 和耐药性结核病 (DR-TB) 显示出希望. 这些更新的选项提高了安全性,有效性和成本效益,特别是在资源有限的环境中.
科学领域:
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是一个关键的全球卫生问题,耐药结核病 (DR-TB) 提出了重大治疗挑战.
- 现有的控制工作受到DR-TB的低成功率的阻碍,需要新的治疗策略.
- 本审查涉及自2022年世卫组织指南以来关于结核病治疗方案的最新证据.
研究的目的:
- 综合现有关于既定和新型治疗方案对药物敏感结核病 (DS-TB) 和药物耐药结核病的安全性和疗效的证据.
- 在成人和儿科患者中评估这些治疗方案.
- 为结核病管理提供临床实践和公共卫生策略的信息.
主要方法:
- 在三个数据库中对2022年1月至2024年2月期间发表的研究进行了系统的文献搜索.
- 搜索的重点是当前和新兴的结核病治疗方案.
- 引用搜索被用来扩大文献综述.
主要成果:
- 35项研究评估了新的DS-TB和DR-TB口服治疗方案,重点关注疗效,安全性和经济影响.
- 基于贝达基林或德拉曼尼德的疗法表现出高的成功率和良好的耐受性.
- 与标准治疗相比,BPaLM疗法表现出更高的疗效和安全性,较短的DR-TB疗法改善了结果并降低了成本,尽管DS-TB疗法的药物费用更高.
结论:
- 目前的证据支持对DR-TB和DS-TB实施更短的治疗方案.
- 这些较短的方案提高了安全性,有效性和成本效益,在资源有限的环境中尤其有利.
- 儿科数据虽然有限,但表明儿童使用更短,更安全的治疗方案可能有好处.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.7K
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
178
相关概念视频
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
